Olfactory Epithelium as a Novel Toxic Target Following an Intravenous Administration of Vincristine to Mice

To delineate morphological characteristics of olfactory lesions induced by vincristine (VCR), a vinca alkaloid derivative with antitumor activity, male BALB/c mice were given a single intravenous injection of 1.95 mg/kg, an estimated 10% lethal dose (designated as day 1). The animals were serially sacrificed on days 2, 3, 5, 10, 15 and 60, and the nasal mucosa was examined histopathologically. Cell death was noted in the olfactory epithelia adjacent to the respiratory epithelia from days 2 to 5. Inflammatory responses were not detected throughout the observation periods. Cell death was identified as apoptotic by the terminal deoxyribonucleotidy l transferase-mediated dUTP-digoxigenin nick-end labeling (TUNEL) assay and electron microscopy. Mitotic figures and proliferating cell nuclear antigen (PCNA)-positive reactions were diffusely scattered in both the basal and sensory cells. On days 10 or after, no prominent histological abnormalities were noted in the olfactory epithelia, which suggests the aforementioned lesions were completely recovered. These results demonstrate that it is essential to perform histopathologica l evaluation of the nasal mucosa during an early preclinical stage for novel antitumor drugs, since olfactory lesions due to the certain compound s like VCR may not be detected by any other procedure.

[1]  Yuko Suzuki,et al.  Basal cells in the mouse olfactory epithelium after axotomy: immunohistochemical and electron-microscopic studies , 1991, Cell and Tissue Research.

[2]  H. Hansson Retinal changes induced by treatment with vincristine and vinblastine , 1972, Documenta Ophthalmologica.

[3]  M. Lishner,et al.  Association between alopecia and response to aggressive chemotherapy in patients with Hodgkin's disease. , 1999, Medical hypotheses.

[4]  A. Farbman,et al.  Supporting cells as phagocytes in the olfactory epithelium after bulbectomy , 1996, The Journal of comparative neurology.

[5]  K. Morgan,et al.  Normal Morphology of the Nasal Passages in Laboratory Rodents , 1996 .

[6]  K. Morgan,et al.  Nonneoplastic Lesions of the Olfactory Mucosa , 1996 .

[7]  A. O'marcaigh,et al.  The Vinca Alkaloids , 1995, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.

[8]  J. Schwob,et al.  Cell cycle of globose basal cells in rat olfactory epithelium , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[9]  M. Bally,et al.  Liposome encapsulated vincristine: preclinical toxicologic and pharmacologic comparison with free vincristine and empty liposomes in mice, rats and dogs , 1994, Anti-cancer drugs.

[10]  D. R. Joyner,et al.  Nasal Diagrams: A Tool for Recording the Distribution of Nasal Lesions in Rats and Mice , 1994, Toxicologic pathology.

[11]  J. Morris,et al.  A physiologically based pharmacokinetic model for nasal uptake and metabolism of nonreactive vapors. , 1993, Toxicology and applied pharmacology.

[12]  V. Schweitzer Ototoxicity of chemotherapeutic agents. , 1993, Otolaryngologic clinics of North America.

[13]  A. Ohnishi,et al.  Clinical and pathological studies on peripheral neuropathy of six Chinese patients with lung cancer: morphometric evaluation of the sural nerve on biopsy. , 1993, Journal of UOEH.

[14]  DM Chikaraishi,et al.  Characterization of potential precursor populations in the mouse olfactory epithelium using immunocytochemistry and autoradiography , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[15]  G. Schwartsmann,et al.  Vinca alkaloids. , 1988, Cancer chemotherapy and biological response modifiers.

[16]  D. Morton,et al.  Animal models for the comparative assessment of neurotoxicity following repeated administration of vinca alkaloids. , 1979, Cancer treatment reports.

[17]  P. Dyck,et al.  Vinca alkaloid neuropathy , 1968, Neurology.